CATALYST PHARMACEUTICALS, INC.: 10-Q filed 2013-11-13
What CATALYST PHARMACEUTICALS, INC. reported in its quarterly report filed 2013-11-13 (fiscal Q3 2013): 28 published measures, 85 facts as tagged in accession 0001193125-13-440258.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-11-13
- Fiscal period
- fiscal Q3 2013
- Accession
- 0001193125-13-440258 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CATALYST PHARMACEUTICALS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 28,694,977 | USD | |
| At 2012-12-31 | 16,789,245 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 6,575,902 | USD | |
| At 2012-12-31 | 2,167,130 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 22,119,075 | USD | |
| At 2012-12-31 | 14,622,115 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 12,962,966 | USD | |
| At 2012-12-31 | 1,409,939 | USD | |
| At 2012-09-30 | 11,973,860 | USD | |
| At 2011-12-31 | 6,029,067 | USD | |
| At 2001-12-31 | 100,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -5,912,059 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -10,799,938 | USD | 273 |
| 2002-01-01 to 2013-09-30 | -52,978,941 | USD | 4291 |
| 2012-07-01 to 2012-09-30 | -2,621,535 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -3,999,801 | USD | 274 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -5,745,415 | USD | 273 |
| 2002-01-01 to 2013-09-30 | -42,320,378 | USD | 4291 |
| 2012-01-01 to 2012-09-30 | -3,546,580 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 9,432 | USD | 273 |
| 2002-01-01 to 2013-09-30 | 164,640 | USD | 4291 |
| 2012-01-01 to 2012-09-30 | 6,882 | USD | 274 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 17,988,693 | USD | 273 |
| 2002-01-01 to 2013-09-30 | 70,036,072 | USD | 4291 |
| 2012-01-01 to 2012-09-30 | 9,498,255 | USD | 274 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | -690,251 | USD | 273 |
| 2002-01-01 to 2013-09-30 | -14,852,728 | USD | 4291 |
| 2012-01-01 to 2012-09-30 | -6,882 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | -52,978,941 | USD | |
| At 2012-12-31 | -42,179,003 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 46,334 | USD | |
| At 2012-12-31 | 53,679 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 46,665 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 133,305 | USD | 273 |
| 2002-01-01 to 2013-09-30 | 6,095,505 | USD | 4291 |
| 2012-07-01 to 2012-09-30 | 45,585 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 135,765 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | -3,245,776 | USD | 92 |
| 2013-01-01 to 2013-09-30 | -7,604,735 | USD | 273 |
| 2002-01-01 to 2013-09-30 | -52,086,373 | USD | 4291 |
| 2012-07-01 to 2012-09-30 | -1,283,713 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -3,715,787 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 28,639,755 | USD | |
| At 2012-12-31 | 16,726,678 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 3,011,661 | USD | |
| At 2012-12-31 | 1,646,665 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 1,473,341 | USD | |
| At 2012-12-31 | 1,365,663 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 3,245,776 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 7,604,735 | USD | 273 |
| 2002-01-01 to 2013-09-30 | 52,575,331 | USD | 4291 |
| 2012-07-01 to 2012-09-30 | 1,283,713 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 3,715,787 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 2,804,352 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 6,028,691 | USD | 273 |
| 2002-01-01 to 2013-09-30 | 34,331,996 | USD | 4291 |
| 2012-07-01 to 2012-09-30 | 654,837 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 1,914,905 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 53,986,937 | shares | |
| At 2012-12-31 | 41,420,687 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 75,044,029 | USD | |
| At 2012-12-31 | 56,759,697 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 133,074 | USD | |
| At 2012-12-31 | 123,642 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 86,740 | USD | |
| At 2012-12-31 | 69,963 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 1,538,320 | USD | |
| At 2012-12-31 | 281,002 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-09-30 | 988,701 | USD | |
| At 2012-12-31 | 1,309,470 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 441,424 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 1,576,044 | USD | 273 |
| 2002-01-01 to 2013-09-30 | 18,243,335 | USD | 4291 |
| 2012-07-01 to 2012-09-30 | 628,876 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 1,800,882 | USD | 274 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-07-01 to 2013-09-30 | 5,707 | USD | 92 |
| 2013-01-01 to 2013-09-30 | 16,777 | USD | 273 |
| 2012-07-01 to 2012-09-30 | 2,725 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 8,236 | USD | 274 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 16,777 | USD | 273 |
| 2002-01-01 to 2013-09-30 | 181,655 | USD | 4291 |
| 2012-01-01 to 2012-09-30 | 8,236 | USD | 274 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-09-30 | 107,678 | USD | 273 |
| 2002-01-01 to 2013-09-30 | 1,473,341 | USD | 4291 |
| 2012-01-01 to 2012-09-30 | 91,975 | USD | 274 |
Inspect the source
- Entity
- CATALYST PHARMACEUTICALS, INC. / CIK 0001369568
- Captured
- 2026-09-21T17:19:25.463Z
- SEC response SHA-256
7cf76a511a9127dd31ed7d53955bbe348f790d8d7fd354d359e6674e7b2af9c9
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001369568.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))